NCT07749313

Brief Summary

  • Study Overview This single-arm prospective clinical trial evaluates the efficacy of gracilis free functional muscle transfer (FFMT) for restoring elbow flexion in patients with late-presenting brachial plexus injuries (≥12 months post-injury) or failed prior reconstructive surgery. The gracilis muscle is the preferred donor due to its reliable vascular pedicle, adequate excursion, long motor nerve, and minimal donor-site morbidity .
  • Primary Objective To assess postoperative elbow flexion strength using the British Medical Research Council (BMRC) grading system following gracilis FFMT neurotized by intercostal nerves (ICN) or spinal accessory nerve (SAN).
  • Secondary Objectives
  • Evaluate active range of motion (AROM)
  • Measure time to first detectable muscle contraction and time to maximum power
  • Assess functional improvement via DASH scores
  • Compare outcomes between ICN and SAN neurotization groups
  • Compare outcomes between pediatric and adult patients
  • Document complications, particularly elbow flexion contracture
  • Key Inclusion Criteria
  • Age 4-50 years
  • Elbow flexion loss or severe weakness for \>12 months following brachial plexus injury (obstetric or traumatic)
  • Weak ipsilateral latissimus dorsi and pectoralis major (\<M3), unsuitable for local muscle transfer
  • Key Exclusion Criteria
  • Age \<4 years (microvascular anastomosis feasibility concerns)
  • Age \>50 years (diminished regenerative capacity)
  • Presentation within 12 months of injury
  • Reconstructable by local muscle or nerve transfer
  • Elbow joint stiffness or contracture
  • Uncontrolled comorbidities or inability to comply with rehabilitation
  • Intervention Gracilis FFMT harvested from the contralateral thigh with:
  • \*\*Neurotization:\*\* ICNs (50%) or SAN (50%)
  • \*\*Vascular anastomosis:\*\* Thoracoacromial artery (77%), thoracodorsal artery (13.6%), or subscapular artery (9.2%)
  • \*\*Muscle tensioning:\*\* Elbow flexed 90-110° during inset
  • Primary Outcome Measure Postoperative elbow flexion power (BMRC grade) at 24-month follow-up
  • Secondary Outcome Measures
  • Active range of motion (goniometry)
  • Time to first clinical contraction
  • Time to maximum power achievement
  • DASH score
  • Complication rate (flap loss, flexion contracture, scarring)
  • Sample Size 22 patients (17 male, 5 female; mean age 13.4±8.7 years)
  • Statistical Considerations
  • Paired t-test for continuous outcomes
  • Wilcoxon signed-rank test for non-parametric data
  • Fisher's exact test for categorical comparisons
  • Significance threshold: p\<0.05
  • Expected Outcomes Based on existing literature, 68-76% of patients achieve functionally useful elbow flexion (≥M3) following gracilis FFMT, with significant improvements in AROM and DASH scores . ICN neurotization may offer faster recovery to maximum power (approximately 9 months vs. 14 months for SAN) without compromising final strength .
  • Trial Registration:\*\* Not reported (retrospective/prospective case series design)

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
22

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 15, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2025

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

May 15, 2026

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

August 1, 2026

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 6, 2026

Completed
Last Updated

August 6, 2026

Status Verified

August 1, 2026

Enrollment Period

1 year

First QC Date

August 1, 2026

Last Update Submit

August 1, 2026

Conditions

Keywords

Free Functional Muscle TransferBrachial Plexus InjurySpinal Accessory Nerve.

Outcome Measures

Primary Outcomes (1)

  • British Medical Research Council (BMRC) muscle power

    elbow flexion power using the British Medical Research Council (BMRC)

    18 months

Secondary Outcomes (3)

  • active and passive range of motion degree

    18 months

  • first detectable clinical sign of muscle contraction

    18 months

  • time to achieve its maximum possible power following rehabilitation

    18 months

Study Arms (2)

Spinal acessory nerve neurotisation

EXPERIMENTAL

necrotizing the free Gracilis by spinal accessory nerve

Procedure: spinal accessory nerve neurotization

Intercostal nerve group

EXPERIMENTAL

necrotizing the free Gracilis by 3 intercostal nerve

Procedure: Intercostal nerve neurotization

Interventions

neurotizing free Gracilis muscle by Spinal accessory nerve

Spinal acessory nerve neurotisation

neurotizing free Gracilis muscle by 3 intercostal nerves

Intercostal nerve group

Eligibility Criteria

Age4 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • More than 12 months after injury

You may not qualify if:

  • younger than 4 years
  • older than 50

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Aswan University Hospitals

Aswān, Aswan Governorate, 32337, Egypt

Location

Related Publications (1)

  • Armangil M, Unsal SS, Yildirim T, Bezirgan U, Keremov A, Adiyaman S, Bilgin SS. Outcome of free gracilis muscle transfer for the restoration of elbow flexion in traumatic brachial plexus palsy. Jt Dis Relat Surg. 2021;32(3):633-641. doi: 10.52312/jdrs.2021.225. Epub 2021 Nov 19.

Related Links

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer of plastic surgery

Study Record Dates

First Submitted

August 1, 2026

First Posted

August 6, 2026

Study Start

January 15, 2024

Primary Completion

January 15, 2025

Study Completion

May 15, 2026

Last Updated

August 6, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will not share

Locations